Literature DB >> 9079810

Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1.

R S Selvan1, L J Zhou, M S Krangel.   

Abstract

Activated human monocytes are a source of numerous beta-chemokines. The present study was conducted to determine whether these cells produce the human beta-chemokine I-309 and to compare the induction requirements of I-309 to those of other beta-chemokines. We demonstrate that appropriately stimulated adherence-purified human peripheral blood monocytes express I-309 transcripts and secreted I-309 protein. Two stimuli, immobilized IgG and lipopolysaccharide (LPS), synergize strongly to induce I-309 gene expression. We further demonstrate that the production of endogenous interleukin (IL)-1alpha plays a crucial role in I-309 induction. Thus, neutralization of endogenous IL-1alpha using an anti-IL-1alpha antiserum inhibits the induction of I-309 transcripts in response to stimulation with immobilized IgG and LPS, and exogenous IL-1alpha or IL-1beta induces I-309 transcripts in monocytes stimulated with immobilized IgG. Immobilized IgG and LPS have the opposite effect on monocyte chemoattractant protein-1 (MCP-1) gene expression, in that the induction observed with either stimulus alone is diminished using the two stimuli in combination. Furthermore, endogenous and exogenous IL-1 can be either stimulatory or inhibitory for MCP-1 gene expression depending on other signals delivered to the monocytes. Immobilized IgG and LPS synergize to induce macrophage inflammatory protein-1alpha transcripts, but endogenous IL-1 does not play a significant role. Thus, each of these beta-chemokine genes is under distinct regulatory control in human monocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9079810     DOI: 10.1002/eji.1830270317

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1.

Authors:  Katarzyna Kazmierczak; Mary Jane Potash
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

2.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

3.  Identification of CCL1 as a Gene Differentially Expressed in CD4 T Cells Expressing TIM-3.

Authors:  Ka Jung Jun; Mi Jin Lee; Dong Chul Shin; Min Yeong Woo; Kyongmin Kim; Sun Park
Journal:  Immune Netw       Date:  2011-08-31       Impact factor: 6.303

4.  A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum.

Authors:  H R Lüttichau; J Stine; T P Boesen; A H Johnsen; D Chantry; J Gerstoft; T W Schwartz
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

5.  Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.

Authors:  A Iellem; M Mariani; R Lang; H Recalde; P Panina-Bordignon; F Sinigaglia; D D'Ambrosio
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

6.  Bovine Lactoferrin-Induced CCL1 Expression Involves Distinct Receptors in Monocyte-Derived Dendritic Cells and Their Monocyte Precursors.

Authors:  Daniela Latorre; Nadia Pulvirenti; Daniela Angela Covino; Barbara Varano; Cristina Purificato; Gabriella Rainaldi; Maria Cristina Gauzzi; Laura Fantuzzi; Lucia Conti; Gloria Donninelli; Manuela Del Cornò; Michela Sabbatucci; Sandra Gessani; Patrizia Puddu
Journal:  Toxins (Basel)       Date:  2015-12-17       Impact factor: 4.546

7.  The human cutaneous chemokine system.

Authors:  Michelle L McCully; Bernhard Moser
Journal:  Front Immunol       Date:  2011-08-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.